Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...
Dyadic Applied BioSolutions ('Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, ...
Finnish researchers unveil Sweeprot, a next-generation sweet protein derived from brazzein, offering zero-calorie, sugar-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback